Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2013

Open Access 01-12-2013 | Research article

Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease

Authors: Aida A Korish, Maha M Arafah

Published in: BMC Complementary Medicine and Therapies | Issue 1/2013

Login to get access

Abstract

Background

Camel milk (CM) is gaining increasing recognition due to its beneficial effects in the control and prevention of multiple health problems. The current study aimed to investigate the effects of CM on the hepatic biochemical and cellular alterations induced by a high-fat, cholesterol-rich diet (HCD), specifically, non-alcoholic fatty liver disease (NAFLD).

Methods

Seventy male Wistar rats were divided into four groups: the Control (C) Group fed a standard diet; the Control + camel milk (CCM) Group fed a standard diet and CM, the Cholesterol (Ch) Group fed a HCD with no CM, and the Cholesterol + camel milk (ChM) Group fed a HCD and CM. The following parameters were investigated in the studied groups; basal, weekly random and final fasting blood glucose levels, intraperitoneal glucose tolerance test (GTT) and insulin tolerance test (ITT), serum insulin, serum lipids, liver functions, lipid peroxidation products, the antioxidant activity of catalase (CAT) and the levels of reduced glutathione (GSH). In addition, HOMA-IR as an index of insulin resistance (IR) and the histopathology of the hepatic tissue were assessed.

Results

The Ch Group developed features similar to those of non-alcoholic steatohepatitis (NASH), characterized by hepatic steatosis; inflammatory cellular infiltration in liver tissue; altered liver functions; and increased total cholesterol, triglycerides, low-density lipoprotein cholesterol, very-low-density lipoprotein cholesterol, atherogenic index (AI), blood glucose, IR, and malondialdehyde (MDA) levels. Additionally, feeding the HCD to animals in the Ch Group decreased CAT activity and the GSH and high-density lipoprotein (HDL) cholesterol levels. Camel milk intake for eight weeks decreased hepatic fat accumulation and inflammatory cellular infiltration, preserved liver function, increased the GSH levels and CAT activity, decreased the MDA levels, and ameliorated the changes in the lipid profile, AI, and IR in animals from the ChM Group.

Conclusions

CM has a unique composition that is rich in minerals; vitamins, insulin and insulin-like protein, and it increased HDL-cholesterol and ameliorated the biochemical and cellular features of NAFLD in rats that received a HCD. The antioxidant effect of CM is a likely mechanism for the altered metabolism and absorption of HCD in the presence of CM. Regular consumption of CM could provide a natural way to protect against NAFLD induced by a high-fat diet.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brunt E: Nonalcoholic steatohepatitis. Semin Liver Dis. 2004, 24: 3-20.PubMed Brunt E: Nonalcoholic steatohepatitis. Semin Liver Dis. 2004, 24: 3-20.PubMed
2.
go back to reference Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, Hultcrantz R: Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatol. 2010, 51: 595-602. 10.1002/hep.23314.CrossRef Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, Hultcrantz R: Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatol. 2010, 51: 595-602. 10.1002/hep.23314.CrossRef
3.
go back to reference Cusi K: Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clin Liver Dis. 2009, 13: 545-563. 10.1016/j.cld.2009.07.009.CrossRefPubMed Cusi K: Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clin Liver Dis. 2009, 13: 545-563. 10.1016/j.cld.2009.07.009.CrossRefPubMed
4.
go back to reference Malhi H, Gores GJ: Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis. 2008, 28: 360-369. 10.1055/s-0028-1091980.CrossRefPubMedPubMedCentral Malhi H, Gores GJ: Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis. 2008, 28: 360-369. 10.1055/s-0028-1091980.CrossRefPubMedPubMedCentral
5.
go back to reference Mukundh NB, Muralidharan P, Balamurugan G: Antihyperlipidemic activity of Pedalium murex (Linn) fruits on high fat diet fed rats. Int J Pharmacol. 2008, 4: 310-313. 10.3923/ijp.2008.310.313.CrossRef Mukundh NB, Muralidharan P, Balamurugan G: Antihyperlipidemic activity of Pedalium murex (Linn) fruits on high fat diet fed rats. Int J Pharmacol. 2008, 4: 310-313. 10.3923/ijp.2008.310.313.CrossRef
6.
go back to reference Lev E: Traditional healing with animals (zootherapy): medieval to present-day Levantine practice. J Ethno pharmacol. 2003, 86: 107-118.CrossRef Lev E: Traditional healing with animals (zootherapy): medieval to present-day Levantine practice. J Ethno pharmacol. 2003, 86: 107-118.CrossRef
7.
go back to reference WHO, IUCN, WWF: Guidelines on the Conservation of Medicinal Plants Gland. 1993, Switzerland: The World Conservation Union (IUCN), in partnership with The World Health Organization (WHO) and World Wide Fund for Nature (WWF) WHO, IUCN, WWF: Guidelines on the Conservation of Medicinal Plants Gland. 1993, Switzerland: The World Conservation Union (IUCN), in partnership with The World Health Organization (WHO) and World Wide Fund for Nature (WWF)
9.
go back to reference Gorakh MD, Sena DC, Jain VK, Sahani MS: Therapeutic utility of camel milk as nutritional supplement against multiple drug resistant patients. In: Proc 2nd Intl Camelid Conf Agro economics of Camelid Farming. Almaty. 2000, 9: 99- Gorakh MD, Sena DC, Jain VK, Sahani MS: Therapeutic utility of camel milk as nutritional supplement against multiple drug resistant patients. In: Proc 2nd Intl Camelid Conf Agro economics of Camelid Farming. Almaty. 2000, 9: 99-
10.
go back to reference Yateem A, Balba MT, Al Surrayai T, Al Mutairi B: Al –Daher: Isolation of lactic acid bacteria with probiotic potential from camel milk. Int J Dairy Sci. 2008, 3: 194-199. 10.3923/ijds.2008.194.199.CrossRef Yateem A, Balba MT, Al Surrayai T, Al Mutairi B: Al –Daher: Isolation of lactic acid bacteria with probiotic potential from camel milk. Int J Dairy Sci. 2008, 3: 194-199. 10.3923/ijds.2008.194.199.CrossRef
11.
go back to reference Al-Awadi FM, Srikumar TS: Trace elements and their distribution in protein fractions of camel milk in comparison to other commonly consumed milks. J Dairy Res. 2001, 68: 463-469.CrossRefPubMed Al-Awadi FM, Srikumar TS: Trace elements and their distribution in protein fractions of camel milk in comparison to other commonly consumed milks. J Dairy Res. 2001, 68: 463-469.CrossRefPubMed
12.
go back to reference El Agamy EI, Nawar M, Shamsia SM, Awad S, Haenlein GF: Are camel milk proteins convenient to the nutrition of cow milk allergic children. Small Ruminant Res. 2009, 82: 1-6. 10.1016/j.smallrumres.2008.12.016.CrossRef El Agamy EI, Nawar M, Shamsia SM, Awad S, Haenlein GF: Are camel milk proteins convenient to the nutrition of cow milk allergic children. Small Ruminant Res. 2009, 82: 1-6. 10.1016/j.smallrumres.2008.12.016.CrossRef
13.
go back to reference Al-Hashem F, Dallak M, Bashir N, Abbas M, Elessa R, Khalil M, Al-Khateeb M: Camel's milk protects against cadmium chloride induced toxicity in white albino rats. Am J Pharmacol and Toxicol. 2009, 4: 107-117. Al-Hashem F, Dallak M, Bashir N, Abbas M, Elessa R, Khalil M, Al-Khateeb M: Camel's milk protects against cadmium chloride induced toxicity in white albino rats. Am J Pharmacol and Toxicol. 2009, 4: 107-117.
14.
go back to reference El Agamy EI, Ruppanner R, Ismail A, Champagne CP, Assaf R: Antibacterial and antiviral activity of camel milk protective proteins. J Dairy Res. 1992, 59: 169-175. 10.1017/S0022029900030417.CrossRefPubMed El Agamy EI, Ruppanner R, Ismail A, Champagne CP, Assaf R: Antibacterial and antiviral activity of camel milk protective proteins. J Dairy Res. 1992, 59: 169-175. 10.1017/S0022029900030417.CrossRefPubMed
15.
go back to reference Rao RB, Gupta RC, Dastur NN: Camel’ milk and milk products. Ind J Dairy Sci. 1970, 23: 71-78. Rao RB, Gupta RC, Dastur NN: Camel’ milk and milk products. Ind J Dairy Sci. 1970, 23: 71-78.
16.
go back to reference Agrawal RP, Budania S, Sharma P, Gupta R, Kochar DK, Panwar RB, Sahani MS: Zero prevalence of diabetes in camel milk consuming Raica community of north-west Rajasthan. India Diabetes Res Clin Pract. 2007, 76: 290-296. 10.1016/j.diabres.2006.09.036.CrossRefPubMed Agrawal RP, Budania S, Sharma P, Gupta R, Kochar DK, Panwar RB, Sahani MS: Zero prevalence of diabetes in camel milk consuming Raica community of north-west Rajasthan. India Diabetes Res Clin Pract. 2007, 76: 290-296. 10.1016/j.diabres.2006.09.036.CrossRefPubMed
17.
go back to reference Agrawal RP, Swami SC, Beniwal R, Kochar DK, Sahani MS, Tuteja FC, Ghouri SK: Effect on camel milk on glycemic control, lipid profile and diabetes quality of life in type-1 diabetes: A randomized prospective controlled cross over study. Indian J Anim Sci. 2003, 73: 1105-1110. Agrawal RP, Swami SC, Beniwal R, Kochar DK, Sahani MS, Tuteja FC, Ghouri SK: Effect on camel milk on glycemic control, lipid profile and diabetes quality of life in type-1 diabetes: A randomized prospective controlled cross over study. Indian J Anim Sci. 2003, 73: 1105-1110.
18.
go back to reference Al Haj OA, Al Kanhal HA: Compositional, technological and nutritional aspects of dromedary camel milk. In Dairy J. 2010, 20: 811-821. 10.1016/j.idairyj.2010.04.003.CrossRef Al Haj OA, Al Kanhal HA: Compositional, technological and nutritional aspects of dromedary camel milk. In Dairy J. 2010, 20: 811-821. 10.1016/j.idairyj.2010.04.003.CrossRef
19.
go back to reference Quan S, Tsuda T, Miyamoto T: Angiotensin 1- converting enzyme inhibitory peptides in skim milk fermented with Lactobacillus helveticus 130B4 from camel milk in Inner Mongolia, China. J Sci Food Agric. 2008, 88: 2688-2692. 10.1002/jsfa.3394.CrossRef Quan S, Tsuda T, Miyamoto T: Angiotensin 1- converting enzyme inhibitory peptides in skim milk fermented with Lactobacillus helveticus 130B4 from camel milk in Inner Mongolia, China. J Sci Food Agric. 2008, 88: 2688-2692. 10.1002/jsfa.3394.CrossRef
20.
go back to reference Majeed NA: Corrective effect of milk of camel on some cancer biomarkers in blood of rats intoxicated with aflatoxin B. J Saudi Chem Soc. 2005, 9: 253-264. Majeed NA: Corrective effect of milk of camel on some cancer biomarkers in blood of rats intoxicated with aflatoxin B. J Saudi Chem Soc. 2005, 9: 253-264.
21.
go back to reference Khan AA, Alzohairy MA: Hepatoprotective effects of camel milk against CCl4-induced hepatotoxicity in rats in rats. Asian J Biochem. 2011, 6: 171-180.CrossRef Khan AA, Alzohairy MA: Hepatoprotective effects of camel milk against CCl4-induced hepatotoxicity in rats in rats. Asian J Biochem. 2011, 6: 171-180.CrossRef
22.
go back to reference Elayan AA, Sulieman AM, Saleh FA: The hypocholesterolemic effect of Gariss and Gariss containing bifidobacteria in rats fed on a cholesterol-enriched diet. Asian J Biochem. 2008, 3: 43-47. 10.3923/ajb.2008.43.47.CrossRef Elayan AA, Sulieman AM, Saleh FA: The hypocholesterolemic effect of Gariss and Gariss containing bifidobacteria in rats fed on a cholesterol-enriched diet. Asian J Biochem. 2008, 3: 43-47. 10.3923/ajb.2008.43.47.CrossRef
23.
go back to reference Ming Z, Xiao-Yan L, Jing L, Zhi-Gang X, Li C: The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2008. 2008, 2008: 704-745. Ming Z, Xiao-Yan L, Jing L, Zhi-Gang X, Li C: The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2008. 2008, 2008: 704-745.
24.
go back to reference Otero P, Bonet B, Herrera E, Robano A: Development of atherosclerosis in the diabetic BALB/c mice prevention with vitamin E administration. Atherosclerosis. 2005, 182: 259-265. 10.1016/j.atherosclerosis.2005.02.024.CrossRefPubMed Otero P, Bonet B, Herrera E, Robano A: Development of atherosclerosis in the diabetic BALB/c mice prevention with vitamin E administration. Atherosclerosis. 2005, 182: 259-265. 10.1016/j.atherosclerosis.2005.02.024.CrossRefPubMed
25.
go back to reference Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder MF: Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem. 1993, 38: 578-582. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder MF: Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem. 1993, 38: 578-582.
26.
go back to reference Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of LDL cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.PubMed Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of LDL cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.PubMed
27.
go back to reference Suanarunsawat T, Ayutthaya WDN, Songsak T, Rattanamahaphoom J: Anti-lipidemic actions of essential oil extracted from Ocimum sanctum L. leaves in rats fed with high cholesterol diet. J Appl Biomed. 2009, 7: 45-53. Suanarunsawat T, Ayutthaya WDN, Songsak T, Rattanamahaphoom J: Anti-lipidemic actions of essential oil extracted from Ocimum sanctum L. leaves in rats fed with high cholesterol diet. J Appl Biomed. 2009, 7: 45-53.
28.
go back to reference Yagi K: Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol. 1998, 108: 101-106.PubMed Yagi K: Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol. 1998, 108: 101-106.PubMed
29.
go back to reference Johansson LH, Borg LAH: A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem. 1988, 174: 331-336. 10.1016/0003-2697(88)90554-4.CrossRefPubMed Johansson LH, Borg LAH: A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem. 1988, 174: 331-336. 10.1016/0003-2697(88)90554-4.CrossRefPubMed
30.
go back to reference Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys. 1959, 82: 70-77. 10.1016/0003-9861(59)90090-6.CrossRefPubMed Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys. 1959, 82: 70-77. 10.1016/0003-9861(59)90090-6.CrossRefPubMed
31.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.CrossRefPubMed
32.
go back to reference Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA; NASH Clinical Research Network (CRN): Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011, 53 (3): 810–-820.CrossRefPubMedPubMedCentral Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA; NASH Clinical Research Network (CRN): Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011, 53 (3): 810–-820.CrossRefPubMedPubMedCentral
33.
go back to reference Xiao J, Guo R, Fung ML, Liong EC, Tipoe GL: Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges. Hepatobiliary Pancreat Dis Int. 2013, 12 (Suppl.2): 125-135.CrossRefPubMed Xiao J, Guo R, Fung ML, Liong EC, Tipoe GL: Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges. Hepatobiliary Pancreat Dis Int. 2013, 12 (Suppl.2): 125-135.CrossRefPubMed
35.
36.
go back to reference Kojda G, Harrison D: Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Car vas Res. 1999, 43: 562-571. 10.1016/S0008-6363(99)00169-8.CrossRef Kojda G, Harrison D: Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Car vas Res. 1999, 43: 562-571. 10.1016/S0008-6363(99)00169-8.CrossRef
37.
go back to reference Feldstein AE, Papouchado BG, Angulo P, Sanderson S, Adams L, Gores GJ: Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2005, 3: 384-389. 10.1016/S1542-3565(04)00616-0.CrossRefPubMed Feldstein AE, Papouchado BG, Angulo P, Sanderson S, Adams L, Gores GJ: Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2005, 3: 384-389. 10.1016/S1542-3565(04)00616-0.CrossRefPubMed
38.
go back to reference Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM: Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatol. 2007, 45: 1366-1374. 10.1002/hep.21655.CrossRef Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM: Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatol. 2007, 45: 1366-1374. 10.1002/hep.21655.CrossRef
39.
go back to reference Schäffler A, Schölmerich J, Büchler C: Mechanisms of disease: adipocytokines and visceral adipose tissue–emerging role in nonalcoholic fatty liver disease. Nat Clin Pract Gastro- enterol Hepatol. 2005, 2: 273-280. 10.1038/ncpgasthep0186.CrossRef Schäffler A, Schölmerich J, Büchler C: Mechanisms of disease: adipocytokines and visceral adipose tissue–emerging role in nonalcoholic fatty liver disease. Nat Clin Pract Gastro- enterol Hepatol. 2005, 2: 273-280. 10.1038/ncpgasthep0186.CrossRef
40.
go back to reference Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J: Beyond insulin resistance in NASH: TNF-alpha or adiponectin?. Hepatol. 2004, 40: 46-54.CrossRef Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J: Beyond insulin resistance in NASH: TNF-alpha or adiponectin?. Hepatol. 2004, 40: 46-54.CrossRef
41.
go back to reference Drotman RP, Lawhorn GT: Serum enzymes as indicators of chemical induced liver damage. Drug Chem Toxicol. 1978, 1: 163-171. 10.3109/01480547809034433.CrossRefPubMed Drotman RP, Lawhorn GT: Serum enzymes as indicators of chemical induced liver damage. Drug Chem Toxicol. 1978, 1: 163-171. 10.3109/01480547809034433.CrossRefPubMed
43.
go back to reference Abu-Lehia IH: Physical and chemical characteristic of camel’s milk fat and its fractions. Food Chem. 1989, 34: 261-271. 10.1016/0308-8146(89)90103-9.CrossRef Abu-Lehia IH: Physical and chemical characteristic of camel’s milk fat and its fractions. Food Chem. 1989, 34: 261-271. 10.1016/0308-8146(89)90103-9.CrossRef
44.
go back to reference Beg OU, Bahr-Lindstrom HV, Zaidi ZH, Jornvall H: Characterization of a camel milk protein rich in proline identifies a new beta casein fragment. Regul Pept. 1986, 15: 55-61. 10.1016/0167-0115(86)90075-3.CrossRefPubMed Beg OU, Bahr-Lindstrom HV, Zaidi ZH, Jornvall H: Characterization of a camel milk protein rich in proline identifies a new beta casein fragment. Regul Pept. 1986, 15: 55-61. 10.1016/0167-0115(86)90075-3.CrossRefPubMed
45.
go back to reference Kamal AM, Salama OA, El Saied KM: Changes in amino acids profile and camel milk protein during the early lactation. Int J Dairy Sci. 2007, 2: 226-234.CrossRef Kamal AM, Salama OA, El Saied KM: Changes in amino acids profile and camel milk protein during the early lactation. Int J Dairy Sci. 2007, 2: 226-234.CrossRef
46.
go back to reference Mohamed BE, Idam NZ: Effect of camel milk on plasma lipid profile of hypercholesteremic rats. OJVRTM. 2011, 15: 314-317. Mohamed BE, Idam NZ: Effect of camel milk on plasma lipid profile of hypercholesteremic rats. OJVRTM. 2011, 15: 314-317.
47.
go back to reference Alhomida AS, Junaid MA, A-Jafari AA: Total, free, short-chain and long-chain acyl carnitine levels in Arabian camel’s milk (Camelus dromedarius). J Ocul Pharmacol Ther. 1997, 13: 381-387. 10.1089/jop.1997.13.381.CrossRefPubMed Alhomida AS, Junaid MA, A-Jafari AA: Total, free, short-chain and long-chain acyl carnitine levels in Arabian camel’s milk (Camelus dromedarius). J Ocul Pharmacol Ther. 1997, 13: 381-387. 10.1089/jop.1997.13.381.CrossRefPubMed
48.
go back to reference Karanth J, Jeevaratnam K: Effect of dietary lipid, carnitine and exercise on lipid profile in rat blood, liver and muscle. Indian J Exp Biol. 2009, 47: 748-753.PubMed Karanth J, Jeevaratnam K: Effect of dietary lipid, carnitine and exercise on lipid profile in rat blood, liver and muscle. Indian J Exp Biol. 2009, 47: 748-753.PubMed
49.
go back to reference Ziamajidi N, Khaghani S, Hassanzadeh G, Vardasbi S, Ahmadian S, Nowrouzi A, Ghaffari SM, Abdirad A: Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. Food Chem Toxicol. 2013, 58: 198-209.CrossRefPubMed Ziamajidi N, Khaghani S, Hassanzadeh G, Vardasbi S, Ahmadian S, Nowrouzi A, Ghaffari SM, Abdirad A: Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. Food Chem Toxicol. 2013, 58: 198-209.CrossRefPubMed
50.
go back to reference Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH: Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol. 2009, 51: 371-379. 10.1016/j.jhep.2009.03.019.CrossRefPubMed Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH: Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol. 2009, 51: 371-379. 10.1016/j.jhep.2009.03.019.CrossRefPubMed
51.
go back to reference Barbagallo M: Effects of vitamin E and glutathione on glucose metabolism: Role of magnesium. Hypertension. 1999, 34: 1002-1006. 10.1161/01.HYP.34.4.1002.CrossRefPubMed Barbagallo M: Effects of vitamin E and glutathione on glucose metabolism: Role of magnesium. Hypertension. 1999, 34: 1002-1006. 10.1161/01.HYP.34.4.1002.CrossRefPubMed
52.
go back to reference Salami M, Moosavi-Movahedi AA, Ehsani MR, Yousefi R, Haertlé T, Jean-Marc Chobert JM, Razavi SH, Henrich R, Balalaie S, Ebadi SA, Pourtakdoost S, Niasari-Naslaji A: Improvement of the antimicrobial and antioxidant activities of camel and bovine whey proteins by limited proteolysis. J Agric Food Chem. 2010, 58 (6): 3297-3302. 10.1021/jf9033283.CrossRefPubMed Salami M, Moosavi-Movahedi AA, Ehsani MR, Yousefi R, Haertlé T, Jean-Marc Chobert JM, Razavi SH, Henrich R, Balalaie S, Ebadi SA, Pourtakdoost S, Niasari-Naslaji A: Improvement of the antimicrobial and antioxidant activities of camel and bovine whey proteins by limited proteolysis. J Agric Food Chem. 2010, 58 (6): 3297-3302. 10.1021/jf9033283.CrossRefPubMed
53.
go back to reference Yakaryilmaz F, Guliter S, Savas B, Erdem O, Ersoy R, Erden E, Akyol G, Bozkaya H, Ozenirler S: Effects of vitamin E treatment on peroxisome proliferator-activated receptor alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study. Intern Med J. 2007, 37: 229-235. 10.1111/j.1445-5994.2006.01295.x.CrossRefPubMed Yakaryilmaz F, Guliter S, Savas B, Erdem O, Ersoy R, Erden E, Akyol G, Bozkaya H, Ozenirler S: Effects of vitamin E treatment on peroxisome proliferator-activated receptor alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study. Intern Med J. 2007, 37: 229-235. 10.1111/j.1445-5994.2006.01295.x.CrossRefPubMed
54.
go back to reference Al-Fartosi KG, Khuon OS, Al-Tae HI: Protective role of camel's milk against paracetamol induced hepatotoxicity in male rats. JPBMS. 2011, 2: 1795-1799. Al-Fartosi KG, Khuon OS, Al-Tae HI: Protective role of camel's milk against paracetamol induced hepatotoxicity in male rats. JPBMS. 2011, 2: 1795-1799.
55.
go back to reference Darwish HA, Abd Raboh NR, Mahdy A: Camel's milk alleviates alcohol-induced liver injury in rats. Food Chem Toxicol. 2012, 50 (5): 1377-83. 10.1016/j.fct.2012.01.016.CrossRefPubMed Darwish HA, Abd Raboh NR, Mahdy A: Camel's milk alleviates alcohol-induced liver injury in rats. Food Chem Toxicol. 2012, 50 (5): 1377-83. 10.1016/j.fct.2012.01.016.CrossRefPubMed
56.
go back to reference Wangoha J, Faraha Z, Puhana Z: Iso-electric focusing of camel milk proteins. Int Dairy J. 1998, 8: 617-621. 10.1016/S0958-6946(98)00092-2.CrossRef Wangoha J, Faraha Z, Puhana Z: Iso-electric focusing of camel milk proteins. Int Dairy J. 1998, 8: 617-621. 10.1016/S0958-6946(98)00092-2.CrossRef
57.
go back to reference Abd El-Mageed NM: Hepatoprotective effect of feeding celery leaves mixed with chicory leaves and barley grains to hypercholesterolemic rats. Pharmacogn Mag. 2011, 7 (26): 151-156. 10.4103/0973-1296.80675.CrossRefPubMedPubMedCentral Abd El-Mageed NM: Hepatoprotective effect of feeding celery leaves mixed with chicory leaves and barley grains to hypercholesterolemic rats. Pharmacogn Mag. 2011, 7 (26): 151-156. 10.4103/0973-1296.80675.CrossRefPubMedPubMedCentral
58.
go back to reference Luo Q, Cai Y, Yan J, Sun M, Corke H: Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci. 2004, 26 (2): 137-149.CrossRef Luo Q, Cai Y, Yan J, Sun M, Corke H: Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci. 2004, 26 (2): 137-149.CrossRef
59.
go back to reference Baumrucker CR, Errondu NE: Insulin like growth factor (IGF) system in the bovine mammary gland and milk. J Mammary Gland Biol Neoplasia. 2000, 5: 53-55. 10.1023/A:1009515232450.CrossRefPubMed Baumrucker CR, Errondu NE: Insulin like growth factor (IGF) system in the bovine mammary gland and milk. J Mammary Gland Biol Neoplasia. 2000, 5: 53-55. 10.1023/A:1009515232450.CrossRefPubMed
Metadata
Title
Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease
Authors
Aida A Korish
Maha M Arafah
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2013
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-13-264

Other articles of this Issue 1/2013

BMC Complementary Medicine and Therapies 1/2013 Go to the issue